[Pathogenesis and therapy of hemorrhage in esophageal varices].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004630:Emergencies; D004932:Esophageal and Gastric Varices / Q000209:etiology / Q000628:therapy*; D020701:Esophagoscopes; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy*; D020699:Gastroscopes; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications; D011170:Portasystemic Shunt, Surgical; D012008:Recurrence; D012306:Risk; D012597:Sclerosing Solutions / Q000627:therapeutic use; D013004:Somatostatin / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D012597:Sclerosing Solutions; D014667:Vasopressins; D013004:Somatostatin
Pathogenese und Therapie der Osophagusvarizenblutung.